Cargando…
Bamlanivimab/casirivimab/imdevimab: Burning, eye pain and lack of efficacy following off-label use: 8 case reports
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136810/ http://dx.doi.org/10.1007/s40278-022-15840-4 |